After completing the Ismaelillo clinical trial in this city and analyzing the results, the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) decided to approve the Authorization for Emergency Use of the Cuban vaccine Abdala for pediatric population in ages between 2 and 11 years. Last week the regulatory entity had authorized the use in the segment between 12 and 18 years.